Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Inflammatory Bowel Diseases

Free Subscription 27.07.2026 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 1 BMC Gastroenterol 2 Clin Gastroenterol Hepatol 2 Clin Res Hepatol Gastroenterol 3 Dig Dis Sci 3 Eur J Gastroenterol Hepatol 2 Gut 4 Inflamm Bowel Dis 5 J Crohns Colitis 1 JAMA 2 Mediators Inflamm 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. BRADBURY M, Tyrrell-Price J
   Editorial on 'Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis'.
   Aliment Pharmacol Ther. 2026 Jul 18. doi: 10.1111/apt.70849.
   PubMed        
   
   

   
   Am J Gastroenterol

2. MARTINELLI M, Salomone S, Strisciuglio C, Zellos A, et al
   Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN.
   Am J Gastroenterol. 2026 Jul 22. doi: 10.14309/ajg.0000000000004140.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. HENG Z, Zhan L, Zhang Y, Xu K, et al
   Meta-analysis: safety and efficacy of ustekinumab in pediatric inflammatory bowel disease patients with anti-TNF failure.
   BMC Gastroenterol. 2026 Jul 20. doi: 10.1186/s12876-026-05078.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

4. MULDERS LGM, Beek KJ, Tielbeek JAW, Zwart M, et al
   Psychometric Development and Internal Validation of a Short Version of the Crohn's Anal Fistula Quality of Life Scale.
   Clin Gastroenterol Hepatol. 2026;24:2255-2264.
   PubMed         Abstract available
   
   
5. RAINE T, Peyrin-Biroulet L, Begun J, Biedermann L, et al
   New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC.
   Clin Gastroenterol Hepatol. 2026 Jul 22:S1542-3565(26)00552.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

6. WAN M, Zhang L, Li X, Yang M, et al
   A Comparative Study of Nintedanib versus Conventional Drugs in the Treatment of Inflammatory Bowel Disease-Associated Intestinal Fibrosis.
   Clin Res Hepatol Gastroenterol. 2026 Jul 24:102888.
   PubMed         Abstract available
   
   
7. HUPE M, Bouguen G, Buisson A, Landman C, et al
   Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN(R)) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
   Clin Res Hepatol Gastroenterol. 2026 Jul 24:102889.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

8. GIULIANI D, Spizzirri A, Vincenzo N, Pennella FP, et al
   Occult Free Perforation in a Patient with Poorly Controlled Crohn's Disease.
   Dig Dis Sci. 2026 Jul 21. doi: 10.1007/s10620-026-10125.
   PubMed        
   
   
9. SMITH J, Bartel C, Warner L, Dhaliwal J, et al
   Systematic Review: Evaluating the Prognostic Value of Granulomas in Crohn's Disease.
   Dig Dis Sci. 2026 Jul 19. doi: 10.1007/s10620-026-10080.
   PubMed         Abstract available
   
   
10. KAMP K, Yoo L, Kale T, Zhang X, et al
    Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial.
    Dig Dis Sci. 2026 Jul 18. doi: 10.1007/s10620-026-10111.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

11. COUTO SOUSA D, Fernandes SR, Da Silva Neves A, Pereira F, et al
    External validation of a prediction score for identifying a mild course of Crohn's disease.
    Eur J Gastroenterol Hepatol. 2026 Jul 20. doi: 10.1097/MEG.0000000000003242.
    PubMed         Abstract available
    
    
12. PSARAKIS G, Drygiannakis I, Foteinogiannopoulou K, Orfanoudaki E, et al
    Renal and urological complications in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2026 Jul 22. doi: 10.1097/MEG.0000000000003249.
    PubMed         Abstract available
    
    
13. GIRI S, Vizhi K, Angadi S, Afzalpurkar S, et al
    Effectiveness of tofacitinib as rescue therapy in biological-naive patients with steroid-refractory acute severe ulcerative colitis: a multicentric retrospective analysis.
    Eur J Gastroenterol Hepatol. 2026 Jul 20. doi: 10.1097/MEG.0000000000003254.
    PubMed         Abstract available
    
    

    
    Gut

14. BOURGONJE AR, Innocenti G, Livanos AE, Prinzensteiner M, et al
    Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.
    Gut. 2026 Jul 23:gutjnl-2025-337762. doi: 10.1136/gutjnl-2025-337762.
    PubMed         Abstract available
    
    
15. WILS P, Nancey S, Messmer E, Bourreille A, et al
    Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.
    Gut. 2026 Jul 24:gutjnl-2026-339158. doi: 10.1136/gutjnl-2026-339158.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

16. UNAL NG, Bakkaloglu OK, Kav T, Eskazan T, et al
    Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study.
    Inflamm Bowel Dis. 2026 Jul 22:izag126. doi: 10.1093.
    PubMed         Abstract available
    
    
17. VANOJAN MJNR, Agbabiaka OO, Kumaresan D, Yahia S, et al
    Appendicectomy in ulcerative colitis: a narrative review of epidemiology, pathophysiology, and emerging therapeutic implications.
    Inflamm Bowel Dis. 2026 Jul 21:izag145. doi: 10.1093.
    PubMed         Abstract available
    
    
18. ELDESOUKI MH, Hafez Y, Salem AE, Alomari M, et al
    Increased risk of respiratory syncytial virus infection in patients with active inflammatory bowel disease: a matched cohort study.
    Inflamm Bowel Dis. 2026 Jul 22:izag134. doi: 10.1093.
    PubMed         Abstract available
    
    
19. NARDONE OM, Yuan Y, Caso F, Pope J, et al
    Classifications of rheumatological extraintestinal manifestations in inflammatory bowel disease: Unmet needs in clinical practice and trials.
    Inflamm Bowel Dis. 2026 Jul 23:izag144. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

20. RIMOLA J, Fernandez-Clotet A, Ordas I
    "Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials" by Bhandari et al.
    J Crohns Colitis. 2026;20:jjag108.
    PubMed        
    
    
21. CARON B, Kirchgesner J, Nachury M, Bouguen G, et al
    Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.
    J Crohns Colitis. 2026;20:jjag102.
    PubMed         Abstract available
    
    
22. QINGQING S
    Methodological and respiratory concerns regarding JAK inhibitor safety in ulcerative colitis.
    J Crohns Colitis. 2026;20:jjag109.
    PubMed        
    
    
23. RAINE T, Danese S, Schreiber S, Gao X, et al
    Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial.
    J Crohns Colitis. 2026;20:jjag104.
    PubMed         Abstract available
    
    
24. PARRA-IZQUIERDO V, Frias Ordonez JS, Eggermont E, Verstockt B, et al
    Intestinal ultrasound for the detection of postoperative recurrence in Crohn's disease: a systematic review and meta-analysis.
    J Crohns Colitis. 2026;20:jjag094.
    PubMed         Abstract available
    
    

    
    JAMA

25. LOEB LP, Davis AM, Kinnucan JA
    Ulcerative Colitis Management in Adults.
    JAMA. 2026 Jul 22. doi: 10.1001/jama.2026.8803.
    PubMed        
    
    

    
    Mediators Inflamm

26. WANG X, Akanyibah FA, Zhang P, Zhou X, et al
    Geniposide Alleviates Inflammatory Bowel Disease by Regulating Intestinal Flora and Arginine Metabolism and Inhibiting the NF-kappaB Pathway Through Targeting Anxa5.
    Mediators Inflamm. 2026;2026:e6231832.
    PubMed         Abstract available
    
    
27. ZHOU X, Ji J, Li W, Wu W, et al
    Deletion of Circadian Rhythms Gene BMAL1 Impairs the Intestinal Epithelial Barrier and Exacerbates Intestinal Inflammation by Inducing Pyroptosis.
    Mediators Inflamm. 2026;2026:e9930240.
    PubMed         Abstract available
    
    

    
    PLoS One

28. HOMSEK ILIC A, Jovanovic M, Markovic S, Vezmar Kovacevic S, et al
    Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.
    PLoS One. 2026;21:e0352967.
    PubMed         Abstract available
    
    
29. LUCAS C, Bontonou M, Aubry M, Ogier-Denis E, et al
    Sequence-robust MRI asymmetry measures for the detection of anoperineal lesions in Crohn's disease on axial pelvic MRI scans.
    PLoS One. 2026;21:e0340243.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum